SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-021441
Filing Date
2023-03-20
Accepted
2023-03-20 16:45:53
Documents
14
Period of Report
2023-03-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea175493-8k_gamidacell.htm   iXBRL 8-K 32121
2 PRESS RELEASE, DATED MARCH 20, 2023 ea175493ex99-1_gamida.htm EX-99.1 10864
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2482
  Complete submission text file 0001213900-23-021441.txt   225970

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE gmda-20230315.xsd EX-101.SCH 3236
5 XBRL LABEL FILE gmda-20230315_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE gmda-20230315_pre.xml EX-101.PRE 22365
8 EXTRACTED XBRL INSTANCE DOCUMENT ea175493-8k_gamidacell_htm.xml XML 3614
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38716 | Film No.: 23746843
SIC: 2836 Biological Products, (No Diagnostic Substances)